The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease
Open accessAbstract
Plasma xanthine oxidase (XO) activity was defined as a source of enhanced vascular superoxide (O \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \setlength{\oddsidemargin}{-69pt} \begin{document} \begin{equation*}{\mathrm{_{2}^{{\cdot}-}}}\end{equation*}\end{document} ) and hydrogen peroxide (H 2 O 2 ) production in both sickle cell disease (SCD) patients and knockout-transgenic SCD mice. There was a significant increase in the plasma XO activity of SCD patients that was similarly reflected in the SCD mouse model. Western blot and enzymatic analysis of liver tissue from SCD mice revealed decreased XO content. Hematoxylin and eosin staining of liver tissue of knockout-transgenic SCD mice indicated extensive hepatocellular injury that was accompanied by increased plasma content of the liver enzyme alanine aminotransferase. Immunocytochemical and enzymatic analysis of XO in thoracic aorta and liver tissue of SCD mice showed increased vessel wall and decreased liver XO, with XO concentrated on and in vascular luminal cells. Steady-state rates of vascular O \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \setlength{\oddsidemargin}{-69pt} \begin{document} \begin{equation*}{\mathrm{_{2}^{{\cdot}-}}}\end{equation*}\end{document} production, as indicated by coelenterazine chemiluminescence, were significantly increased, and nitric oxide ( ⋅ NO)-dependent vasorelaxation of aortic ring segments was severely impaired in SCD mice, implying oxidative inactivation of ⋅ NO. Pretreatment of aortic vessels with the superoxide dismutase mimetic manganese 5,10,15,20-tetrakis( N -ethylpyridinium-2-yl)porphyrin markedly decreased O \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \setlength{\oddsidemargin}{-69pt} \begin{document} \begin{equation*}{\mathrm{_{2}^{{\cdot}-}}}\end{equation*}\end{document} levels and significantly restored acetylcholine-dependent relaxation, whereas catalase had no effect. These data reveal that episodes of intrahepatic hypoxia-reoxygenation associated with SCD can induce the release of XO into the circulation from the liver. This circulating XO can then bind avidly to vessel luminal cells and impair vascular function by creating an oxidative milieu and catalytically consuming ⋅ NO via O \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \setlength{\oddsidemargin}{-69pt} \begin{document} \begin{equation*}{\mathrm{_{2}^{{\cdot}-}}}\end{equation*}\end{document} -dependent mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The binding of plasma XO to ECs can lead to vascular dysfunction (45, 71, 562, 612, 1010).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
Self-citationRed Cell Metabolism: A Manual of Biochemical Methods.
(1971) · Annals of Internal Medicine · doi:10.7326/0003-4819-75-6-985_1 · Cited by 2,327
Radí, R., Beckman, J. S., Bush, K. M., & Freeman, B. Α. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90224-7 · Cited by 2,201
Self-citationRubbo, H., Radí, R., Trujillo, M., Telleri, R., Kalyanaraman, B., Barnes, S., KIRK, M. C., & Freeman, B. Α. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47160-8 · Cited by 1,350
Self-citationFormation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite
van der Vliet, A., Eiserich, J. P., Halliwell, B., & Cross, C. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.7617 · Cited by 780
Enroth, C., Eger, B. T., Okamoto, K., Nishino, T., Nishino, T., & Pai, E. F. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.20.10723 · Cited by 733
Superoxide and peroxynitrite inatherosclerosis.
White, C. R., Brock, T. A., Chang, L. Y., Crapo, J. D., BRISCOE, P. M., Ku, D. D., Bradley, W. A., Gianturco, S. H., Gore, J. Z., & Freeman, B. Α. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.3.1044 · Cited by 684
Self-citationKissner, R., Nauser, T., Bugnon, P., Lye, P. G., & Koppenol, W. H. (1997) · Chemical Research in Toxicology · doi:10.1021/tx970160x · Cited by 629
Allopurinol Normalizes Endothelial Dysfunction in Type 2 Diabetics With Mild Hypertension
Butler, R., Morris, A. D., Belch, J. J. F., Hill, A., & Struthers, A. D. (2000) · Hypertension · doi:10.1161/01.hyp.35.3.746 · Cited by 463
Spontaneous oxygen radical generation by sickle erythrocytes.
Hebbel, R. P., Eaton, J. W., Balasingam, M., & Steinberg, M. H. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110724 · Cited by 444
Flagged first, then by citations
Research works printed but not linked: 8
- 10.1182/blood.V94.5.1555 · DOI
- C O Enwonwu Med Sci Res 17, 997–998 (1989).
- C R Morris, F A Kuypers, S Larkin, N Sweeters, J Simon, E P Vichinsky, L A Styles Br J Haematol 111, 498–500 (2000).
- S Giler, O Sperling, S Brosh, I Urca, A De Vries Isr J Med Sci 11, 1225 (1975).
- K Wolko, J Krawczynski Mater Med Pol 6, 95–98 (1974).
- D A Parks, D N Granger Am J Physiol 245, G285–G289 (1983).
- Y Yokoyama, J S Beckman, T K Beckman, J K Wheat, T G Cash, B A Freeman, D A Parks Am J Physiol 258, G564–G570 (1990).
- E A Kowaluk, P Seth, H L Fung J Pharmacol Exp Ther 262, 916–922 (1992).
Cited by
Sorted by citations
Items 301–391 of 391
Biochemistry of Molybdopterin Nitrate/Nitrite Reductases
Kelley, E. E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804273-1.00013-2 · Cited by 7
The Role of Platelets in Sickle Cell Disease
Brzóska, T., Kato, G. J., & Sundd, P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813456-6.00031-x · Cited by 6
Maxwell, L. G., Goodwin, S. R., Mancuso, T. J., Baum, V. C., Zuckerberg, A. L., Morgan, P. G., Motoyama, E. K., Davis, P. J., & Sullivan, K. (2011) · Elsevier eBooks · doi:10.1016/b978-0-323-06612-9.00036-5 · Cited by 6
Olaniyi, J. A., & ARINOLA, O. G. (2010) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-0901-30 · Cited by 6
Sickle cell disease: Only one road, but different pathways for inflammation
Vilas-Boas, W., Cerqueira, B. A. V., Pitanga, T. N., Seixas, M. O., Menezes, J. F., Cajado, C., Adôrno, E. V., & Gonçalves, M. D. S. (2012) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2012.324071 · Cited by 6
Hemolytic Anemia Associated Pulmonary Hypertension
Machado, R. F., & Gladwin, M. T. (2006) · Elsevier eBooks · doi:10.1016/b978-1-4160-2246-6.50018-3 · Cited by 6
Self-citationPritchard, K. A., Rivera, A., Hillery, C. A., & Brugnara, C. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.042 · Cited by 5
Sickle cell disease: loss of the blood's WD40?
Lancaster, J. R. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00199-8 · Cited by 5
Bernardo, V. S., Torres, F. F., Zucão, A. C. A., Chaves, N. A., Santana, I. L. R., & da Silva, D. G. H. (2025) · Tissue and Cell · doi:10.1016/j.tice.2024.102717 · Cited by 4
Pathophysiology of Pulmonary Arterial Hypertension
Farber, H. W. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-075-5_4 · Cited by 3
Pereira, D. A., Silveira, T. H. R., Calmasini, F. B., & Silva, F. H. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1357176 · Cited by 4
Saudi guidelines on diagnosis and treatment of pulmonary arterial hypertension
Idrees, M. M., Al-Hajjaj, M. S., Khan, J., Hazmi, M. A., Alanezi, M. O., Saleemi, S., Sanai, F. M., Kashour, T. S., Wali, S., & Barst, R. J. (2008) · Annals of Thoracic Medicine · doi:10.4103/1817-1737.39589 · Cited by 14
Role of iloprost and bosentan in pulmonary arterial hypertension
Saleh, J.-E. A. (2008) · Nigerian Journal of Medicine · doi:10.4314/njm.v17i1.37347 · Cited by 4
Dietlin, T. A., Cua, D. J., Burke, K. A., Lund, B. T., & van der Veen, R. C. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.04.029 · Cited by 4
Elhawary, E. E., Khedr, S. F., Nagy, H. M., El-Bradey, M. H., & Elshanshory, M. R. (2022) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000002435 · Cited by 3
Peroxiredoxin‐2 recycling is slower in denser and pediatric sickle cell red cells
Oh, J., Bae, C. Y., Kasztan, M., Pollock, D. M., Russell, R. T., Lebensburger, J. D., & Patel, R. P. (2022) · The FASEB Journal · doi:10.1096/fj.202200052r · Cited by 3
Self-citationLeg Ulcers in Sickle Cell Disease: A Multifactorial Analysis Highlights the Hemolytic Profile
Santos, E. D. C., Santana, P. V. B., de Jesus, L. L. S., Melo, G. I. V., Yahouédéhou, S. C. M. A., da Guarda, C. C., Santiago, R. P., Fiuza, L. M., Carvalho, S. P., dos Santos, L. O., et al. (2023) · Hematology Reports · doi:10.3390/hematolrep15010013 · Cited by 5
Ahmed, S. G., & Ibrahim, U. A. (2023) · Nigerian Journal of Basic and Clinical Sciences. · doi:10.4103/njbcs.njbcs_55_22 · Cited by 3
Elbarbary, N. S., Ismail, E. A. R., Roushdy, A. M., & Fahmy, E. (2015) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2015.11.001 · Cited by 3
Balushi, H. W. M. A., Rees, D. C., Brewin, J. N., Hannemann, A., & Gibson, J. S. (2018) · Physiological Reports · doi:10.14814/phy2.13626 · Cited by 2
Priapism in sickle-cell disease: Emergency room intervention
Akinbami, A., Uche, E. I., & Dosunmu, A. O. (2017) · Annals of Tropical Pathology · doi:10.4103/atp.atp_17_17 · Cited by 3
Tsai, A. G., Cabrales, P., Young, M. A., Winslow, R. M., & Intaglietta, M. (2014) · Artificial Cells Nanomedicine and Biotechnology · doi:10.3109/21691401.2014.936063 · Cited by 3
Superoxide dismutase activity in sickle cell anemia patients during crisis and in steady State
Uche, E. I., Olowoselu, F. O., Augustine, B., Suleiman, A., Ismail, A., Oluwole, E. O., Akinbami, A., & Onwah, L. (2020) · Journal of Applied Hematology · doi:10.4103/joah.joah_87_19 · Cited by 3
Sickle Cell Disease Erythrocyte Stiffness and Cytoadhesion Investigated via Atomic Force Microscopy
Maciaszek, J. L. (2013) · OpenCommons at University of Connecticut (University of Connecticut) · Cited by 3
Munoz, C. J., Pires, I. S., Lucas, D., Muller, C. R., Martinez, J., Gopal, S., Palmer, A. F., & Cabrales, P. (2026) · Blood Advances · doi:10.1182/bloodadvances.2025018529 · Cited by 2
PATHOPHYSIOLOGY OF HEMOGLOBIN AND ITS DISORDERS
Steinberg, M. H. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.012 · Cited by 3
Do we kNOw how HSP90 and eNOS mediate lung injury in sickle cell disease?
Schwartz, J. H., White, C. A., & Freeman, B. Α. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00362.2003 · Cited by 2
Self-citationChange of Plasma Xanthine Oxidase Activity by Intermittent Hepatic Ischemia-Reperfusion
Ha, S. J., Kim, J. H., Park, S.-S., Kim, I., Baek, W.-Y., & Lim, D. G. (2004) · Korean Journal of Anesthesiology · doi:10.4097/kjae.2004.47.5.692 · Cited by 2
Rheology and Vascular Pathobiology in Sickle Cell Disease and Thalassemia
Kaul, D. K. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.013 · Cited by 2
Renin-Angiotensin Blockade Reduces Readmission for Acute Chest Syndrome in Sickle Cell Disease
Wamkpah, N. S., Shrestha, A., Salzman, G. A., Simon, S., Suman, S., Poisner, A. M., & Molteni, A. (2022) · Cureus · doi:10.7759/cureus.23567 · Cited by 2
Pulmonary Complications of Hematologic Diseases
Machado, R. F., & Gladwin, M. T. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-3383-5.00094-4 · Cited by 2
Self-citationAmino acids and the erythrocyte under stress?
Machado, R. F. (2007) · Blood · doi:10.1182/blood-2007-09-113407 · Cited by 2
Nitric oxide-based therapies in sickle cell disease: The evidence continues to mount*
Machado, R. F. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000251844.19490.3b · Cited by 2
Kaul, D. K. (2008) · Comprehensive physiology · doi:10.1002/cphy.cp020417 · Cited by 2
Interventions for treating pulmonary hypertension in people with sickle cell disease or thalassaemia
Bowers, A. S., Francis, D., & Bennett, N. R. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011752 · Cited by 1
Joffre, J., Raia, L., Urbina, T., Bonny, V., Gabarre, P., Missri, L., Baudel, J.-L., Coppo, P., Guidet, B., Maury, É., et al. (2023) · Critical Care · doi:10.1186/s13054-023-04405-w · Cited by 1
Modulation of Immunity to Respiratory Viral Infection
Snelgrove, R. J., Findlay, E. G., & Hussell, T. (2006) · Future Virology · doi:10.2217/17460794.1.4.471 · Cited by 1
Haemolysis in PNH: Depletion of Nitric Oxide
Hill, A. (2017) · Springer eBooks · doi:10.1007/978-4-431-56003-6_7 · Cited by 2
Comments on Contemporary Methods of Oxygen and Nitrogen Free Radical Detection
(2005) · CRC Press eBooks · doi:10.1201/9781420030853.pt3 · Cited by 1
Erhabor, O., Adias, T. C., Erhabor, T., Mgbere, O. O., Usman, S., & Egenti, B. N. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.105685 · Cited by 1
Ruiz-Núñez, B., Rooij, S. A. D., Offringa, P. J., Schuitemaker, G. E., Teerlink, T., Booi, H. S. M., Dijck-Brouwer, J., & Muskiet, F. A. J. (2013) · Free Radicals and Antioxidants · doi:10.1016/j.fra.2013.10.003 · Cited by 1
The Safety of Chelators for Iron Overload in Sickle Cell Disease: A Brief Systematic Review
Radwan, B., & Boşgelmez, İ. İ. (2019) · Acta Medica · doi:10.32552/2019.actamedica.368 · Cited by 1
Kaul, D. K. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374530-9.00019-x · Cited by 1
Rescuing Decrepit Soluble Guanylate Cyclase: A Therapy for Sickle Cell Disease?
Schumacker, P. T. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0003ed · Cited by 1
Schulz, A., Disch, A. C., Melcher, I., Haas, N. P., & Schaser, K. D. (2008) · Der Unfallchirurg · doi:10.1007/s00113-008-1446-4
Animal Models of Hemoglobinopathies and Thalassemia
Fabry, M. E. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.017
Influence of oxygen on vascular tone during acute hypoxia
Dada, J. (2013) · ORCA Online Research @Cardiff (Cardiff University)
Buettner, G. R., Oberley, L. W., Spitz, D. R., & Domann, F. E. (2003)
Kara, E., Sakarya, A., Var, A., & Vatansever, S. (2010)
Seixas, M. O. (2009) · Americanae (AECID Library)
NEW APPROACHES TO THE TREATMENT OF HEMOGLOBINOPATHIES AND THALASSEMIA
Steinberg, M. H., Forget, B. G., Higgs, D. R., & Weatherall, D. J. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.039
C-Reactive Protein and Interleukin-6 Are Decreased in Transgenic Sickle Cell Mice
Archer, D. R., Stiles, J. K., Newman, G. W., Quarshie, A., Hsu, L. L.-Y., Sayavongsa, P., Perry, J., Jackson, E., & Hibbert, J. M. (2008)
Wagner, M. C. (2006) · SMARTech Repository (Georgia Institute of Technology)
Hemostatic Aspects of Sickle Cell Disease
Ataga, K. I., & Lottenberg, R. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2296-9.00046-4
l-Arginine Therapy in Sickle Cell Disease
Morris, C. R. (2016) · Springer eBooks · doi:10.1007/978-3-319-26009-9_39
Evaluation of Drug-Induced Liver Injury in an In Vitro Oxidative Stress Inflammation System
Maruf, A. A. (2014) · TSpace (University of Toronto)
Markers of coagulation activation in patients with hemoglobinopathy in Western Saudi Arabia
Adam, S. S., & Zaher, G. (2017) · Journal of Applied Hematology · doi:10.4103/1658-5127.204426
The Defective Arginine-Nitric Oxide Pathway in Sickle Cell Disease
Morris, C. R., & Kato, G. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804273-1.00026-0
Hemostatic Aspects of Sickle Cell Disease
Ataga, K. I., & Lottenberg, R. (2007) · Elsevier eBooks · doi:10.1016/b978-141602401-9.10047-1
Oxidative Stress and Pulmonary Vascular Disorders
Groß, C., Aggarwal, S., Rafikov, R., & Black, S. M. (2014) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-4939-0679-6_27
Ha, O., & Fasola, F. (2020) · American Journal of Laboratory Medicine · doi:10.11648/j.ajlm.20200502.13
Jain, N., & Dawale, P. (2021) · International Journal of Trend in Scientific Research and Development
Batinic̈‐Haberle, I. (2004) · Defense Technical Information Center (DTIC)
Self-citationOnyedikachi, O. C. (2021) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2021.39.006366
Pulmonary Complications of Hematologic Disease
Machado, R. F., & Gladwin, M. T. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-4710-0.00084-5
Self-citationValidação de genes candidatos envolvidos na retinopatia falciforme
Bertozzo, V. D. H. E. (2022) · doi:10.47749/t/unicamp.2021.1239374
Kaul, D. K. (1984) · Comprehensive physiology · doi:10.1002/j.2040-4603.1984.tb01026.x
Perfil oxidativo e bioquímico em pacientes que apresentam anemia falciforme ou traço falciforme
Manfredini, V. (2008) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Joffre, J., Raia, L., Urbina, T., Bonny, V., Gabarre, P., Missri, L., Baudel, J.-L., Coppo, P., Guidet, B., Maury, É., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26576348
Mechanisms of delayed wound healing in various models of human diseases
Nguyen, V. T. (2015) · theses.fr (ABES) · doi:10.70675/ef58963ez0008z4633zbd9azd255022aa1be · Cited by 1
Impact de la drépanocytose sur les fonctions et le développement placentaires
Cordier, A. (2019) · theses.fr (ABES) · doi:10.70675/21415cfczcca9z4e06za093zf967ef5be6df
Modulation et rôle des paramètres hémorhéologiques dans la physiopathologie de la drépanocytose
Griffon, C. (2018) · theses.fr (ABES) · doi:10.70675/ad2b1266zad9fz4070z9fd7z1abcbdd2b38f
Anomalies de la mitophagie au cours de la maturation érythroïde dans la drépanocytose
Martino, S. (2020) · theses.fr (ABES) · doi:10.70675/a131d6c1z5236z45e9z93e3zec879bb0d4ff
Étude phénotypique et fonctionnelle des progéniteurs myéloïdes dans la drépanocytose
Serra, M. (2023) · theses.fr (ABES) · doi:10.70675/b36dbc93zd0f3z4c37za604z5321671ab3e3
Gwarzo, D. H., Kuliya‐Gwarzo, A., Yusuf, A., Abdullahi, S., Idris, I., Jobbi, Y. D., Abdulsalam, K., Galadanci, A., Borodo, A., Musa, B., et al. (2026) · Nigerian Journal of Clinical Practice · doi:10.4103/njcp.njcp_853_25
Lucero, M. J., Nozik‐Grayck, E., Hassell, K., Irwin, D. C., Buehler, P. W., & Ferguson, S. K. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27188170
CT Features of Sickle Cell Disease-Associated Pulmonary Hypertension
Molla, N., Sewaralthahab, S. S., Alotaibi, R. A., Alymni, A. A., Nakha, W. M. A., Alquwayi, N., Abdulaziz, K. A., & Alsaigh, N. A. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15197611
REGULATION OF THE HUMAN XANTHINE OXIDOREDUCTASE GENE
Martelin, E. (2004) · Työväentutkimus Vuosikirja
Role of Oxidative Stress in ED: Unraveling the Molecular Mechanism
Musicki, B., & Burnett, A. L. “. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-776-7_28
Metadata
- Authors
- Aslan, M., Ryan, T. M., Adler, B., Townes, T. M., Parks, D. A., Thompson, J. A., Tousson, A., Gladwin, M. T., Patel, R. P., Tarpey, M. M., Batinic-Haberle, I., White, C. R., & Freeman, B. A.
- Affiliations
- National Institutes of Health (US)
- Departments of Anesthesiology, Biochemistry and Molecular Genetics, Pathology, Medicine, and Surgery, Center for Free Radical Biology, Imaging Facility and Comprehensive Sickle Cell Disease Center, University of Alabama, Birmingham, AL 35233; Critical Care Medicine Department of the Warren G. Magnuson Clinical Center, and Laboratory of Chemical Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892; and Department of...
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2001-12-18
- Volume
- 98
- Issue
- 26
- Pages
- 15215-15220
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC65009
- OpenAlex
- W2014093734
- Cited by
- 391
- References
- 67
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 5 · 2023: 12 · 2022: 9 · 2021: 14 · 2020: 14 · 2019: 18 · 2018: 15 · 2017: 14 · 2016: 9 · 2015: 17 · 2014: 17 · 2013: 16 · 2012: 11
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p60hl058418-05)
- National Heart, Lung, and Blood Institute (R01HL64937, R01HL064937, P6-HL-58418, R01HL058115, R01-HL-58115)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- sickle cell disease, xanthine oxidase, superoxide, nitric oxide, hydrogen peroxide, hepatocyte injury, aorta, superoxide dismutase mimetic, manganese porphyrin
- MeSH terms
- Alanine Transaminase, Anemia, Sickle Cell, Animals, Endothelium, Vascular, Erythrocytes, Humans, Muscle Relaxation, Nitric Oxide, Superoxides, Xanthine Oxidase, Mice, Knockout, Mice, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review